ICN Pharmaceuticals Inc., of Costa Mesa, Calif., named David Watt executive vice president of its worldwide biomedicals group and Gregory Keever executive vice president and general counsel.
MDS Pharma Services, of Montreal, added Qing-An Jiao as site manager to its staff at its facility in Bejing.
MediChem Life Sciences, of Chicago, appointed Alex Burgin director of biochemistry, Robin Clark director of protein research and Sridhar Prasad director of crystallography in its Emerald BioStructures structural proteomics unit. Separately, it added Jasbir Singh as vice president of medicinal chemistry.
Myriad Genetics Inc., of Salt Lake City, named Edward Swabb senior vice president and head of development of its Myriad Pharmaceuticals subsidiary. It also named Mary-Helen Binger director of clinical development and project manager for MPC-7869, its prostate cancer compound.
Prolinx Inc., of Bothell, Wash., promoted Robert Kaiser to chief technology officer and Karin Hughes to vice president, research and development.
Quark Biotech Inc., of Cleveland, appointed Boaz Laor president of U.S. operations and named Michael Halliburton as U.S. controller.
Reliant Pharmaceuticals LLC, of Liberty Corner, N.J., appointed Lawrence Gyenes executive vice president and chief financial officer.
Serologicals Corp., of Atlanta, elected Ralph Christoffersen to its board.
Tanox Inc., of Houston, appointed Seenu Srinivasan as vice president of manufacturing operations and Gary Glandon as vice president of human resources.